Clinical Trial Update: Efficacy and Safety Study of Oral Solithromycin Compared to Intramuscular Ceftriaxone Plus Oral Azithromycin in the Treatment of Patients With Gonorrhea [Phase 3]

View source ↗

Summary

Phase 3 trial comparing oral solithromycin to intramuscular ceftriaxone plus oral azithromycin for uncomplicated urogenital gonorrhea completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gonorrhea
• Uncomplicated Urogenital Gonorrhea

Drugs mentioned

• Azithromycin (azithromycin)
• Solithromycin (solithromycin)
• ceftriaxone (ceftriaxone sodium)

Snippet

Sponsor: Melinta Therapeutics, Inc. | Conditions: Uncomplicated Urogenital Gonorrhea | Phase 3 | Status: COMPLETED